Literature DB >> 9395894

The SCID mouse mutant: definition and potential use as a model for immune and hematological disorders.

V Leblond1, B Autran, J Y Cesbron.   

Abstract

Mice homozygous for a SCID mutation (SCID mice) are severely deficient in T and B lymphocytes. The absence of effector T and B cells has encouraged investigators to attempt engraftment of SCID mice with human fetal tissues, mature lymphocytes, hematopoietic progenitors and tumors. SCID mice can be reconstituted with human lymphocytes and are of interest for studying normal and abnormal lymphocyte development and function. SCID mice are also providing an in vivo model of infectious diseases. In addition, SCID mice readily support normal and pathologic human hematopoiesis differentiation and is useful for testing innovative hematological disease therapy. SCID mice with a fully functional human immune or hematopoietic system therefore seem to be extremely valuable for biomedical research.

Entities:  

Mesh:

Year:  1997        PMID: 9395894     DOI: 10.1007/s00282-997-0213-2

Source DB:  PubMed          Journal:  Hematol Cell Ther        ISSN: 1269-3286


  7 in total

1.  Significant growth inhibition of orthotopic pancreatic ductal adenocarcinoma by CpG oligonucleotides in immunodeficient mice.

Authors:  J Tepel; O Dagvadorj; M Kapischke; B Sipos; A Leins; B Kremer; H Kalthoff
Journal:  Int J Colorectal Dis       Date:  2005-08-16       Impact factor: 2.571

Review 2.  Genetically modified pigs to model human diseases.

Authors:  Tatiana Flisikowska; Alexander Kind; Angelika Schnieke
Journal:  J Appl Genet       Date:  2014-02       Impact factor: 3.240

3.  p-[123I]iodo-L-phenylalanine for detection of pancreatic cancer: basic investigations of the uptake characteristics in primary human pancreatic tumour cells and evaluation in in vivo models of human pancreatic adenocarcinoma.

Authors:  Samuel Samnick; Bernd F M Romeike; Boris Kubuschok; Dirk Hellwig; Michaela Amon; Wolfgang Feiden; Michael D Menger; Carl-Martin Kirsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-14       Impact factor: 9.236

4.  The humanin analogue (HNG) prevents temozolomide-induced male germ cell apoptosis and other adverse effects in severe combined immuno-deficiency (SCID) mice bearing human medulloblastoma.

Authors:  Yue Jia; Yanhe Lue; Ronald S Swerdloff; Joseph L Lasky; Eduard H Panosyan; Jenny Dai-Ju; Christina Wang
Journal:  Exp Mol Pathol       Date:  2019-05-11       Impact factor: 4.401

5.  177Lu-DOTA-HH1, a novel anti-CD37 radio-immunoconjugate: a study of toxicity in nude mice.

Authors:  Ada H V Repetto-Llamazares; Roy H Larsen; Anna Maria Giusti; Elena Riccardi; Øyvind S Bruland; Pål Kristian Selbo; Jostein Dahle
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

Review 6.  Using mouse models to study function of transcriptional factors in T cell development.

Authors:  Peng Li; Yiren Xiao; Zhixin Liu; Pentao Liu
Journal:  Cell Regen (Lond)       Date:  2012-10-10

7.  Identification and Characterization of Novel Rat Polyomavirus 2 in a Colony of X-SCID Rats by P-PIT assay.

Authors:  Lora H Rigatti; Tuna Toptan; Joseph T Newsome; Patrick S Moore; Yuan Chang
Journal:  mSphere       Date:  2016-12-21       Impact factor: 4.389

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.